Skip to content
healthcare.dev

Eribulin Mesylate

NDC 0781-3391, eribulin mesylate, injection, from Sandoz Inc.

Product NDC
0781-3391
Status
Listed
Labeler
Sandoz Inc
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214310
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0781-3391 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERIBULIN MESYLATE.5 mg/mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
0781-3391-94007813391941 VIAL in 1 CARTON (0781-3391-94) / 2 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d122f0a4-aff7-49f7-8cf1-06bc2883ad43
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0781-3391

Use it

Look up 0781-3391 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0781-3391 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0781-3391. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.